ARX vs NAN

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

ARX

AROA BIO FPO [ARX]

57MEDIUM

NAN

NANOSONICS FPO [NAN]

52MEDIUM

Score Breakdown

ARX NAN
Technical
38
49
Catalyst
50
53
Sentiment
50
50
Fundamental
95
94
Momentum
55
41
Risk Gate
50
40

Key Metrics

ARX Metric NAN
$202.9MMarket Cap$965.5M
314KAvg Volume (20d)440K
N/AShort Interest+6.9%
$0.80052-Week High$4.770
$0.49552-Week Low$2.960
-0.8%Daily Change-0.3%
$0.580Reference Price$3.220
+4.9%ROE+10.1%
+4.5%Profit Margin+9.9%

Active Signals

ARX Signals

●RSI drifting toward oversold territory — worth watching
●Trading below both moving averages — the trend is working against this one
●Above-average volume (1.6x) on a red day — sellers in control
●Sitting near support — this level has held before and could attract buyers again
●Drifting lower — down 3.3% over the last 5 days
●Below the 200-day average — the long-term trend is still working against it
●Cash positive / operating cashflow positive
●Low P/S ratio (2.0x)

NAN Signals

●MACD momentum is losing steam
●Stochastic is deep in oversold territory — bounce conditions forming
●Below the 200-day average — the long-term trend is still working against it
●Cash positive / operating cashflow positive
●Low P/S ratio (4.7x)
●Moderate revenue growth (+9%)
●Piotroski F-Score strong (8/9, low-confidence approx)
●EPS estimates revised upward (+3pts)

Ask Scout AI to compare ARX and NAN in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

ARX vs NOX →ARX vs NYR →ARX vs PAR →ARX vs SPL →ATH vs EIQ →
ARX Full Analysis → NAN Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).